In pancreatic cancer, uPAR immunoreactivity is consistently detected in the highly fibrotic, inflammatory or desmoplastic areas adjacent to cancer cells [120], both in the primary tumors and their paired liver metastasis [145]. This evidence concerns the gene PLAUR and pancreatic neoplasm.